1 |
ACR-16
| [0] | - | - | - | [1] 8 8 |
2 |
Alprazolam
| [1] Alprazolam Alprazolam | [1] D00225
D00225
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 8 8, 75 |
3 |
Amantadine
| [3] Amantadine Amantadine; AMANTADINE HYDROCHLORIDE; GOCOVRI | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [4] 6 6, 8, 13, 127 |
4 |
Atomoxetine
| [2] Atomoxetine Atomoxetine; Strattera | [2] D02574
D02574
,
D07473
| [1] SLC6A2 SLC6A2 💬 | [1] Synaptic vesicle cycle Synaptic vesicle cycle 💬 | [4] 6 6, 8, 13, 17 |
5 |
Bevantolol
| [1] Bevantolol Bevantolol | - | - | - | [1] 8 8 |
6 |
Biotin
| [4] BIOTIN BIOTIN; Biotina; D-BIOTIN; Vitamin B7 | [1] D00029
D00029
| - | - | [5] 2 2, 8, 10, 13, 20 |
7 |
Branaplam
| [1] Branaplam Branaplam | - | - | - | [2] 3 3, 8 |
8 |
Bupropion
| [2] Bupropion Bupropion; Bupropion Hydrochloride | [3] D00817
D00817
,
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [5] 8 8, 18, 21, 96, 171 |
9 |
Cannabidiol
| [3] Cannabidiol Cannabidiol; Epidyolex; SATIVEX | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [19] 2 2, 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
10 |
Citalopram
| [1] Citalopram Citalopram | [2] D00822
D00822
,
D07704
| [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 |
11 |
Creatine
| [1] Creatine Creatine | - | - | - | [16] 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
12 |
Cysteamine
| [8] 2-aminoethanethiol 2-aminoethanethiol; Beta-Mercaptoethylamine; CYSTADROPS; CYSTAGON; Cysteamine; Mercaptamina; Mercaptamine; PROCYSBI | [2] D03634
D03634
,
D03635
| - | - | [4] 8 8, 19, 21, 299 |
13 |
Deutetrabenazine
| [1] Deutetrabenazine Deutetrabenazine | [1] D10701
D10701
| [1] SLC18A2 SLC18A2 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 8 8 |
14 |
Dextromethorphan
| [4] Dextromethorphan Dextromethorphan; Dextromethorphan hydrobromide; Dextrometorfano; Nuedexta | [3] D00848
D00848
,
D03742
,
D03744
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [11] 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
15 |
Digoxin
| [1] Digoxin Digoxin | [1] D00298
D00298
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | [18] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 8 8, 46, 210 |
16 |
Dronabinol
| [4] Delta-9-tetrahydrocannabinol Delta-9-tetrahydrocannabinol; DRONABINOL; SATIVEX; Tetrahydrocannabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [8] 2 2, 8, 13, 36, 46, 96, 271, 298 |
17 |
Epigallocatechin
| [1] Epigallocatechin Epigallocatechin | - | - | - | [5] 8 8, 13, 28, 85, 113 |
18 |
Epigallocatechin gallate
| [2] EGCG EGCG; Epigallocatechin gallate | - | - | - | [9] 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
19 |
Fenofibrate
| [1] Fenofibrate Fenofibrate | [1] D00565
D00565
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [5] 8 8, 79, 93, 94, 265 |
20 |
Fludeoxyglucose (18F)
| [3] 18F-FDG 18F-FDG; Fludeoxyglucose; Fludeoxyglucose F 18 | - | - | - | [14] 5 5, 6, 7, 8, 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 |
21 |
GSK-356278
| [0] | - | - | - | [1] 8 8 |
22 |
Haloperidol
| [1] Haloperidol Haloperidol | [2] D00136
D00136
,
D01898
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 8 8 |
23 |
Icosapent
| [2] Eicosapentaenoic acid Eicosapentaenoic acid; Icosapent | [1] D08061
D08061
| - | - | [11] 8 8, 46, 48, 49, 96, 97, 113, 296, 297, 301, 338 |
24 |
Icosapent ethyl
| [2] Ethyl-EPA Ethyl-EPA; Icosapent | [1] D01892
D01892
| - | - | [2] 8 8, 296 |
25 |
Idebenone
| [2] IDEBENONE IDEBENONE; Raxone | [1] D01750
D01750
| - | - | [6] 6 6, 8, 13, 18, 113, 302 |
26 |
Indopan
| [0] | - | - | - | [4] 8 8, 46, 97, 321 |
27 |
Ketoconazole
| [2] Ketoconazole Ketoconazole; NIZORAL | [1] D00351
D00351
| [1] CYP17A1 CYP17A1 💬 | [6] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [3] 8 8, 13, 75 |
28 |
Laquinimod
| [1] LAQUINIMOD LAQUINIMOD | - | - | - | [4] 8 8, 13, 49, 96 |
29 |
Latrepirdine
| [2] Dimebon Dimebon; Latrepirdine | [1] D09917
D09917
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [22] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 |
30 |
LAX-101
| [1] LAX-101 LAX-101 | - | - | - | [1] 8 8 |
31 |
Lithium citrate
| [2] Lithium Lithium; LITHIUM CITRATE | [1] D04749
D04749
| - | - | [5] 2 2, 5, 6, 7, 8 |
32 |
Manganese citrate
| [1] Release Release | - | - | - | [12] 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
33 |
Melatonin
| [2] Circadin Circadin; Melatonin | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [12] 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
34 |
Memantine
| [3] EBIXA EBIXA; Memantine; MEMANTINE HYDROCHLORIDE | [2] D04905
D04905
,
D08174
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [7] 2 2, 6, 8, 13, 49, 127, 205 |
35 |
Metformin
| [5] Metformin Metformin; Metformin HCl; METFORMIN HYDROCHLORIDE; METFORMINA; Metformine | [2] D00944
D00944
,
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [24] 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
36 |
Minocycline
| [3] MINOCYCLINE MINOCYCLINE; MINOCYCLINE HYDROCHLORIDE; Minomycin | [2] D00850
D00850
,
D05045
| - | - | [14] 2 2, 6, 8, 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 |
37 |
Neflamapimod
| [1] Neflamapimod Neflamapimod | [1] D10959
D10959
| [4] MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | [62] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | [1] 8 8 |
38 |
Nilotinib
| [2] Nilotinib Nilotinib; TASIGNA | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 6 6, 8, 34, 51, 86 |
39 |
Olanzapine
| [2] Olanzapine Olanzapine; Zyprexa | [2] D00454
D00454
,
D06623
| [11] ADRA1A ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 2 2, 8 |
40 |
Omeprazole
| [5] Losec Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
41 |
Phenylbutyric acid
| [4] 4-phenylbutyrate 4-phenylbutyrate; Pheburane; Phenylbutyrate; Sodium phenylbutyrate | - | - | - | [14] 2 2, 3, 6, 8, 15, 21, 93, 94, 231, 244, 251, 297, 299, 338 |
42 |
Phosphorus
| [2] Phosphorous Phosphorous; Phosphorus | - | - | - | [3] 8 8, 58, 238 |
43 |
Pridopidine
| [1] Pridopidine Pridopidine | [1] D09953
D09953
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3] 2 2, 6, 8 |
44 |
Quinidine
| [4] Nuedexta Nuedexta; Quinidina; Quinidine; Quinidine Sulfate | [4] D00642
D00642
,
D00643
,
D02272
,
D08458
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 2 2, 8, 13 |
45 |
Ramelteon
| [2] Ramelteon Ramelteon; ROZEREM | [1] D02689
D02689
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 8, 46 |
46 |
Resveratrol
| [1] Resveratrol Resveratrol | - | - | - | [6] 2 2, 8, 18, 89, 113, 299 |
47 |
Rilmenidine
| [2] HYPERIUM HYPERIUM; Rilmenidine | [1] D08482
D08482
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 8 8 |
48 |
Riluzole
| [2] RILUTEK RILUTEK; RILUZOLE | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [9] 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
49 |
Risperidone
| [1] Risperidone Risperidone | [1] D00426
D00426
| [2] DRD2 DRD2, HTR2A 💬 | [11] Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [5] 8 8, 156, 179, 187, 206 |
50 |
Rolipram
| [1] Rolipram Rolipram | [1] D01783
D01783
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 8 8, 13 |
51 |
Selisistat
| [1] Selisistat Selisistat | - | - | - | [1] 8 8 |
52 |
Tetrabenazine
| [2] Tetrabenazine Tetrabenazine; Xenazine | [1] D08575
D08575
| [1] SLC18A2 SLC18A2 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 8 8 |
53 |
Thiamine
| [2] Thiamine Thiamine; Vitamin B1 | [1] D08580
D08580
| - | - | [5] 8 8, 13, 93, 145, 265 |
54 |
Tiapride
| [0] | [1] D08590
D08590
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 8 8 |
55 |
Triheptanoin
| [1] Triheptanoin Triheptanoin | [1] D11465
D11465
| - | - | [10] 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
56 |
Ubidecarenone
| [3] Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | [1] D01065
D01065
| - | - | [13] 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 193, 214, 215 |
57 |
Ubiquinol
| [1] Ubiquinol Ubiquinol | - | - | - | [3] 6 6, 8, 17 |
58 |
Ursodeoxycholic acid
| [4] UDCA UDCA; URSODEOXYCHOLIC ACID; Ursodiol; Ursofalk | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [14] 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 |
59 |
Valbenazine
| [1] Valbenazine Valbenazine | [1] D10675
D10675
| [1] SLC18A2 SLC18A2 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 8 8 |
60 |
Warfarin
| [2] Warfarin Warfarin; Warfarin Sodium | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [13] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |